Teladoc Health, Inc. $TDOC Shares Purchased by WINTON GROUP Ltd

WINTON GROUP Ltd lifted its position in shares of Teladoc Health, Inc. (NYSE:TDOC) by 402.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 227,100 shares of the health services provider’s stock after purchasing an additional 181,900 shares during the period. WINTON GROUP Ltd owned about 0.13% of Teladoc Health worth $1,926,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Creative Planning grew its position in shares of Teladoc Health by 7.7% during the third quarter. Creative Planning now owns 20,567 shares of the health services provider’s stock worth $159,000 after buying an additional 1,462 shares in the last quarter. Versant Capital Management Inc grew its position in shares of Teladoc Health by 33.3% during the 2nd quarter. Versant Capital Management Inc now owns 8,207 shares of the health services provider’s stock valued at $70,000 after buying an additional 2,052 shares during the last quarter. Syon Capital LLC grew its holdings in shares of Teladoc Health by 19.1% during the fourth quarter. Syon Capital LLC now owns 14,140 shares of the health services provider’s stock valued at $99,000 after purchasing an additional 2,264 shares during the last quarter. ProShare Advisors LLC grew its stake in Teladoc Health by 8.2% during the 4th quarter. ProShare Advisors LLC now owns 32,532 shares of the health services provider’s stock worth $228,000 after buying an additional 2,457 shares during the last quarter. Finally, PNC Financial Services Group Inc. increased its holdings in shares of Teladoc Health by 177.7% in the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after acquiring an additional 2,810 shares during the period. Institutional investors and hedge funds own 76.82% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on TDOC shares. Weiss Ratings restated a “sell (d-)” rating on shares of Teladoc Health in a research report on Wednesday, August 19th. Citigroup cut their target price on shares of Teladoc Health from $11.00 to $7.50 and set a “neutral” rating for the company in a research note on Monday, August 3rd. Bank of America increased their price objective on Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a research report on Tuesday, July 7th. Finally, Canaccord Genuity Group decreased their target price on Teladoc Health from $11.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. Five research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $7.54.

Teladoc Health Stock Up 1.1%

Shares of NYSE:TDOC opened at $6.16 on Friday. The company’s fifty day moving average is $7.51 and its two-hundred day moving average is $6.75. The company has a market cap of $1.12 billion, a P/E ratio of -6.22 and a beta of 2.12. Teladoc Health, Inc. has a 12-month low of $4.40 and a 12-month high of $9.89.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.25) by $0.04. The business had revenue of $606.93 million for the quarter, compared to the consensus estimate of $615.44 million. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%.Teladoc Health’s revenue for the quarter was down 4.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.19) earnings per share. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. Equities research analysts anticipate that Teladoc Health, Inc. will post -0.9 earnings per share for the current year.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.